Ristidic, 1.5 mg, hard capsules
Ristidic, 3.0 mg, hard capsules
Ristidic, 4.5 mg, hard capsules
Ristidic, 6.0 mg, hard capsules
Rivastigmine
The active substance of Ristidic is rivastigmine.
Rivastigmine belongs to a group of substances called cholinesterase inhibitors. In patients with Alzheimer's disease or Parkinson's disease dementia, certain brain cells die, which reduces the levels of the neurotransmitter acetylcholine (a substance that allows nerve cells to communicate with each other).
The action of rivastigmine is to block the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase. By blocking the action of these enzymes, Ristidic increases the levels of acetylcholine in the brain, which helps to alleviate the symptoms of Alzheimer's disease.
Ristidic is used to treat adult patients with mild to moderate Alzheimer's disease, a progressive brain disease that causes gradual memory, intellectual, and behavioral disorders. The capsules can also be used to treat dementia in adult patients with Parkinson's disease.
If this situation applies to you, tell your doctor and do not take Ristidic.
Before starting treatment with Ristidic, discuss this with your doctor:
If any of the above apply to you, your doctor may need to monitor you more closely while taking this medicine.
If you have stopped taking Ristidic for more than three days, do not take the next dose until you have talked to your doctor.
Ristidic should not be used in children and adolescents to treat Alzheimer's disease.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Ristidic should not be taken with other similar-acting medicines. Ristidic may affect the action of anticholinergic medicines (medicines used to relieve stomach cramps, treat Parkinson's disease, or prevent motion sickness).
Ristidic should not be taken with metoclopramide (a medicine used to relieve or prevent nausea and vomiting). Taking these two medicines together may cause disorders such as stiffness of the limbs and hand tremors.
If you need to undergo surgery during treatment with Ristidic, tell your doctor before receiving general anesthesia, as Ristidic may increase the action of certain muscle relaxants used during general anesthesia.
Caution should be exercised when Ristidic is used with beta-adrenergic blocking agents (such as atenolol, used to treat high blood pressure, angina, and other heart diseases). Taking these two medicines together may cause disorders such as slow heart rate (bradycardia) leading to fainting or loss of consciousness.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you are pregnant, your doctor will need to assess the benefits of taking Ristidic against the possible effects on the unborn baby. Ristidic should not be taken during pregnancy unless it is absolutely necessary.
You should not breastfeed while taking Ristidic.
Your doctor will inform you whether your condition allows you to drive or use machines safely. Ristidic may cause dizziness and drowsiness, mainly during the initial treatment period or when increasing the dose.
If you feel dizzy or drowsy, do not drive, operate machinery, or perform any other tasks that require concentration.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor, pharmacist, or nurse.
Your doctor will tell you what dose of Ristidic to take.
Your doctor will regularly check if the medicine is working for you. During treatment with this medicine, your doctor will also monitor your weight.
If you have stopped taking Ristidic for more than three days, do not take the next dose until you have talked to your doctor.
In case of accidental ingestion of a higher dose of Ristidic than recommended, inform your doctor, as medical attention may be necessary. In some people who have accidentally taken too much Ristidic, nausea (vomiting), vomiting, diarrhea, high blood pressure, and hallucinations have been observed. Slow heart rate and fainting may also occur.
If you accidentally miss a dose of Ristidic, wait and take the next dose at the usual scheduled time. Do not take a double dose to make up for the missed dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Ristidic can cause side effects, although not everybody gets them.
Side effects may occur more frequently during the initial treatment period or when increasing the dose. Side effects usually resolve slowly as your body gets used to the treatment.
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
In these patients, some side effects occur more frequently. They may also experience additional symptoms:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Frequency not known(cannot be estimated from the available data)
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Medicinal Product Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw,
phone: +48 22 49 21 301
Fax: +48 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
Contents of the capsule:
Capsule shell:
Printing ink:
Each Ristidic 1.5 mg capsule contains 1.5 mg of rivastigmine.
Each Ristidic 3.0 mg capsule contains 3.0 mg of rivastigmine.
Each Ristidic 4.5 mg capsule contains 4.5 mg of rivastigmine.
Each Ristidic 6.0 mg capsule contains 6.0 mg of rivastigmine.
Ristidic 1.5 mg: yellow/yellow, hard gelatin capsules with the imprint “RIVA 1.5 mg” in black ink on the lower part, containing a white or almost white, granular powder equivalent to 1.5 mg of rivastigmine.
Ristidic 3.0 mg: light orange/light orange, hard gelatin capsules with the imprint “RIVA 3mg” in black ink on the lower part, containing a white or almost white, granular powder equivalent to 3.0 mg of rivastigmine.
Ristidic 4.5 mg: caramel/caramel, hard gelatin capsules with the imprint “RIVA 4.5mg” in black ink on the lower part, containing a white or almost white, granular powder equivalent to 4.5 mg of rivastigmine.
Ristidic 6.0 mg: light orange/caramel, hard gelatin capsules with the imprint “RIVA 6 mg” in black ink on the lower part, containing a white or almost white, granular powder equivalent to 6.0 mg of rivastigmine.
The capsules are packed in blisters. Three different pack sizes are available (28, 56, and 112 capsules). Not all pack sizes may be marketed.
Bausch Health Ireland Limited
3013 Lake Drive
Citywest Business Campus
Dublin 24, D24PPT3
Ireland
Bausch Health Poland sp. z o.o.
ul. Przemysłowa 2
35-959 Rzeszów
Genepharm S.A.
18th km Marathonos Avenue,
153 51 Pallini Attikis
Greece
This medicinal product is authorised in the Member States of the European Economic Area under the following names:
NL: Ristidic 1,5 / 3 / 4,5 / 6 mg capsules, hard
PL: Ristidic
SK: Ristidic 1,5 / 3/ 4,5 / 6 mg tvrdé kapsule
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.